Skip to main content

Advertisement

SpringerLink
Log in

The HIV pipeline

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Mechanisms of action in the pipeline.

References

  1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. WHO [online], (2013).

  2. Araújo, L. A. L. & Almeida, S. E. M. HIV-1 diversity in the envelope glycoproteins: implications for viral entry inhibition. Viruses 5, 595–604 (2013).

    Article  Google Scholar 

  3. GBI research. HIV therapeutics in major developed market to 2019. GBIHC328MR (2014).

Download references

Author information

Authors and Affiliations

  1. Angel Wong is an analyst at GBI Research, Bolton, BL1 2AH, UK.,

    Angel Wong

Authors
  1. Angel Wong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Angel Wong.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wong, A. The HIV pipeline. Nat Rev Drug Discov 13, 649–650 (2014). https://doi.org/10.1038/nrd4364

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd4364

  • Springer Nature Limited

Search

Navigation